Survival benefit from liver transplantation for patients with and without hepatocellular carcinoma-Reference-Cited by-同舟云学术

Survival benefit from liver transplantation for patients with and without hepatocellular carcinoma

Published:2023-12 Issue:12 Volume:5 Page:100907
ISSN:2589-5559
Container-title:JHEP Reports
language:en
Short-container-title:JHEP Reports

Author:

Goudsmit Ben F.J.,Ilaria Prosepe ^ORCID,Tushuizen Maarten E.,Mazzaferro Vincenzo,Alwayn Ian P.J.^ORCID,van Hoek Bart^ORCID,Braat Andries E.^ORCID,Putter Hein

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology,Immunology and Allergy,Internal Medicine

Reference46 articles.

1. Allocation of liver grafts worldwide – is there a best system?;Tschuor;J Hepatol,2019

2. Hyponatremia and mortality among patients on the liver-transplant waiting list;Kim;N Engl J Med,2008

3. Validation of the model for end-stage liver disease sodium (MELD-Na) score in the eurotransplant region;Goudsmit;Am J Transpl,2021

4. Is resectable hepatocellular carcinoma a contraindication to liver transplantation? A novel decision model based on “number of patients needed to transplant” as measure of transplant benefit;Vitale;J Hepatol,2014

5. Projected outcomes of 6-month delay in exception points versus an equivalent model for end-stage liver disease score for hepatocellular carcinoma liver transplant candidates;Alver;Liver Transpl,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. European Society for Organ Transplantation (ESOT) Consensus Statement on Outcome Measures in Liver Transplantation According to Value-Based Health Care;Transplant International;2024-01-25

2. Liver Transplantation for Hepatocellular Carcinoma: A Narrative Review and A Glimpse into The Future;Seminars in Liver Disease;2024-01-11

3. Liver transplantation and liver resection as alternative treatments for primary hepatobiliary and secondary liver tumors: Competitors or allies?;Hepatobiliary & Pancreatic Diseases International;2023-12